Susquehanna International Group
ONCY

Susquehanna International Group’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Susquehanna International Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,200
Closed -$5K – 10806
2015
Q2 		$5K Sell
10,200
-37,000
-78% -$25.1K ﹤0.01% 10045
2015
Q1 		$35K Buy
47,200
+34,300
+266% +$22K ﹤0.01% 9209
2014
Q4 		$7K Buy
+12,900
New +$7.8K ﹤0.01% 9533
2014
Q3 		– Sell
-13,100
Closed -$17K – 10442
2014
Q2 		$17K Sell
13,100
-127,900
-91% -$183K ﹤0.01% 9688
2014
Q1 		$282K Buy
141,000
+105,500
+297% +$178K ﹤0.01% 7684
2013
Q4 		$55K Sell
35,500
-59,600
-63% -$134K ﹤0.01% 8779
2013
Q3 		$232K Buy
95,100
+42,500
+81% +$118K ﹤0.01% 7565
2013
Q2 		$151K Buy
+52,600
New +$145K ﹤0.01% 7639

Other funds holding ONCY

VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Susquehanna International Group's ONCY Position: Q1 2015 in Review

Susquehanna International Group sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2015, closing a stake of 10,471 shares — an estimated $6.72K sold.

Susquehanna International Group first reported a position in ONCY in Q3 2013 and held it in 4 quarters. The position peaked at $83K in Q3 2013. 29 funds tracked by Wall St. Rank hold ONCY as of Q1 2015.

  • Susquehanna International Group reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2015 after selling out during the quarter.
  • Susquehanna International Group sold 10,471 ONCOLYTICS BIOTECH INC shares in Q1 2015, an estimated $6.72K.
  • Susquehanna International Group first reported a position in ONCOLYTICS BIOTECH INC in Q3 2013 and held it in 4 quarters.
  • Susquehanna International Group's ONCOLYTICS BIOTECH INC position peaked at $83K in Q3 2013.
  • 29 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2015.

Based on Susquehanna International Group's 13F filing for Q1 2015, filed 15 May 2015.